SEC Form 4 · accession 0001104659-18-071671
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason B. Shandell
Officer — President and General Counsel · Director
Period of report
Dec 3, 2018
Accepted (ET)
Dec 6, 2018 · 3:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 3, 2018 | M | 16,630 | $10.48 | A | 200,445 | D | |
| Common Stock | Dec 3, 2018 | S | 16,630 | $22.44 | D | 183,815 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $10.48 | Dec 3, 2018 | M | 16,630 | D | — | Sep 28, 2022 | Common Stock | 16,630 | 0 | D |
Explanation of responses
- F1Includes 325 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2018.
- F2The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2018.
- F3Shares subject to the option are fully vested and immediately exercisable.